Skye Bioscience
Stock Forecast, Prediction & Price Target

Skye Bioscience Financial Estimates

Skye Bioscience Revenue Estimates

Skye Bioscience EBITDA Estimates

Skye Bioscience Earnings per Share Estimates

Passed Analyst forecast
Metric 12/31/2021 12/31/2022 12/31/2023 12/31/2025 12/31/2026
Revenue
 
% change YoY
$0
 
N/A
$0
 
0%
$0
 
0%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
Net Income
 
% change YoY
$-8.52M
 
N/A
$-19.48M
 
-128.59%
$-37.64M
 
-93.23%
Avg: $-33.31M
Low: $-9.17M
High: $-5.53M
avg. 11.49%
Avg: $-44.26M
Low: $-11.27M
High: $-10.36M
avg. -32.87%
EBITDA
 
% change YoY
$-7.81M
 
N/A
$-12.09M
 
-54.73%
$-13.54M
 
-12.03%
Avg: $0
Low: $0
High: $0
avg. 100%
Avg: $0
Low: $0
High: $0
avg. 0%
EPS
 
% change YoY
-$5.24
 
N/A
-$9.82
 
-87.40%
-$5.37
 
45.31%
Avg: -$1.06
Low: -$1.31
High: -$0.79
avg. 80.32%
Avg: -$1.55
Low: -$1.61
High: -$1.48
avg. -46.21%
Operating Expenses
 
% change YoY
$7.84M
 
N/A
$12.10M
 
54.26%
$13.54M
 
11.90%
Avg: $0
Low: $0
High: $0
avg. -100%
Avg: $0
Low: $0
High: $0
avg. 0%

FAQ

What is Skye Bioscience stock earnings growth forecast?

Wall Street analysts estimate the annual average earnings growth rate of -10.68% in 2025-2026.

We have gathered data from 2 analysts. Their low estimate is -9.17M, average is -33.31M and high is -5.53M.

What is Skye Bioscience stock revenue growth forecast?

We have gathered data from 3 analysts. Their low revenue estimate is N/A, average is N/A and high is N/A.

What is Skye Bioscience stock earnings per share growth forecast?

Wall Street analysts forecast annual average earnings growth of 17.05% in 2025-2026.

We have gathered data from 2 analysts. Their low earnings per share estimate is -$1.31, average is -$1.06 and high is $-0.79.

What is the best performing analyst?

In the last twelve months analysts have been covering Skye Bioscience stock. The most successful analyst is Jay Olson.